Inactivation of CDKN2A by DNA hypermethylation is now thought to be one of the earliest events during lung cancer development ([54] and references therein) and is observed in hyperplasia and carcinoma in situ[34], [55], [56]. The gene discussed is CDKN2A; the disease is in situ carcinoma.